Human medicines European public assessment report (EPAR): Ibandronic acid Accord, ibandronic acid, Date of authorisation: 18/11/2012, Revision: 17, Status: Authorised

26 September 2025

Human medicines European public assessment report (EPAR): Tigecycline Accord, tigecycline, Date of authorisation: 17/04/2020, Revision: 7, Status: Authorised

26 September 2025

Minutes of the COMP meeting 15-17 July 2025

26 September 2025

Human medicines European public assessment report (EPAR): Dovato, dolutegravir,lamivudine, Date of authorisation: 10/06/2022, Revision: 17, Status: Authorised

26 September 2025

Enpr-EMA Coordinating Group and networks meeting June 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, 11 June 2025

26 September 2025

List of medicines under additional monitoring

26 September 2025

Human medicines European public assessment report (EPAR): Prasugrel Viatris (previously Prasugrel Mylan), prasugrel, Date of authorisation: 15/05/2018, Revision: 13, Status: Authorised

26 September 2025

Human medicines European public assessment report (EPAR): Hizentra, human normal immunoglobulin (SCIg), Date of authorisation: 14/04/2011, Revision: 27, Status: Authorised

26 September 2025

Human medicines European public assessment report (EPAR): Voranigo, vorasidenib, Date of authorisation: 17/09/2025, Status: Authorised

26 September 2025

Minutes - PDCO minutes of the 22-25 July 2025 meeting

26 September 2025